Ashleigh Hooimeyer
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 20, 2026
Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta-analysis.Ashleigh Hooimeyer, Eliza J McEwin, Zhicheng Wang
|Aug 04, 2025
How does the Content and Dissemination of Communications on the Risks of Medicines Affect Prescriber Awareness, Knowledge, and Behaviour: A Systematic Review.Lucy T Perry, Annim Mohammad, Ashleigh Hooimeyer
|Jun 25, 2025
Safety Warnings on the Same Harmful Effects of Medicines: A Comparison of Four National Regulators.Lucy T Perry, Alice Bhasale, Ashleigh Hooimeyer
|Jan 13, 2025
Post-Market Evidence for Cancer Medicines in Regulatory and Clinical Decision-Making: A Scoping Review.Eliza J McEwin, Ashleigh Hooimeyer, Barbara J Mintzes
|May 31, 2023
Conflict of interest policies at Australian medical schools.Ashleigh Hooimeyer, Travis Lines, Janet Mirzaei
|Nov 10, 2020
Regulatory post-market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies.Ashleigh Hooimeyer, Alice Bhasale, Lucy Perry
Pageof 1
